COURTNEY HINDES: Open Payments
NPI 1598437121 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$782 in 59 payments from 13 companies in 2025. Trend: 2023 $487 · 2024 $731 · 2025 $782
Food & beverage: $782
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $289 |
| Novo Nordisk Inc | 12 | $148 |
| Lilly USA, LLC | 5 | $84 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| GlaxoSmithKline, LLC. | 3 | $47 |
| PFIZER INC. | 1 | $33 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $23 |
| Hologic Sales and Service, LLC | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
Products named: VRAYLAR, Ozempic, MOUNJARO, XIFAXAN, TRELEGY ELLIPTA, UBRELVY, QULIPTA, Wegovy.
Industry payments across NC — which companies pay providers there.
